학술논문
Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab.
Document Type
Article
Author
Source
Subject
*CHRONIC lymphocytic leukemia
*FLUDARABINE
*CYCLOPHOSPHAMIDE
*PATIENTS
*
*
*
Language
ISSN
0887-6924
Abstract
A letter to the editor is presented regarding the clinical outcome for chronic lymphocytic leukemia (CLL) patients treated with fludarabine, cyclophosphamide, and rituximab (FCR).